514336 GENESIS

Genesis IBRC India Share Price

 

 

Start SIP in GENESIS

Start SIP

Performance

  • Low
  • ₹87
  • High
  • ₹91
  • 52 Week Low
  • ₹17
  • 52 Week High
  • ₹185
  • Open Price₹90
  • Previous Close₹91
  • Volume194

Investment Returns

  • Over 1 Month -37.19%
  • Over 3 Month + 38.79%
  • Over 6 Month + 346.31%
  • Over 1 Year + 416.31%

Smart Investing Starts Here Start SIP with Genesis IBRC India for Steady Growth!

Invest Now

Genesis IBRC India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -506.7
  • PEG Ratio
  • 11.4
  • Market Cap Cr
  • 117
  • P/B Ratio
  • 14
  • Average True Range
  • 4.83
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -13.18
  • RSI
  • 26.6
  • MFI
  • 72.37

Genesis IBRC India Financials

Genesis IBRC India Technicals

EMA & SMA

Current Price
₹90.20
-0.7 (-0.77%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹102.73
  • 50 Day
  • ₹110.90
  • 100 Day
  • ₹94.06
  • 200 Day
  • ₹66.69

Resistance and Support

89.28 Pivot Speed
  • R3 95.22
  • R2 92.93
  • R1 91.57
  • S1 87.92
  • S2 85.63
  • S3 84.27

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Genesis Ibrc India has an operating revenue of Rs. 4.38 Cr. on a trailing 12-month basis. Pre-tax margin of 0% needs improvement, ROE of 41% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 98 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 79 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Overall, the stock has some strength but we want to see some buyer interest and further fundamental performance to qualify as a growth stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Genesis IBRC India Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Quarterly Results
2025-08-14 Quarterly Results
2025-05-29 Audited Results
2025-02-14 Quarterly Results
2024-11-14 Quarterly Results

Genesis IBRC India F&O

Genesis IBRC India Shareholding Pattern

11.33%
32.01%
56.66%

Genesis IBRC India FAQs

Genesis IBRC India share price is ₹90 As on 30 December, 2025 | 05:54

The Market Cap of Genesis IBRC India is ₹117.3 Cr As on 30 December, 2025 | 05:54

The P/E ratio of Genesis IBRC India is -506.7 As on 30 December, 2025 | 05:54

The PB ratio of Genesis IBRC India is 14 As on 30 December, 2025 | 05:54

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23